[Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests].
Alzheimer disease is a neurodegenerative condition that affects cognitive, behavioral and global functioning of patients. Currently and due to the lack of conclusive biological testing, Alzheimer's disease diagnosis is based primarily on clinical criteria. Since its early diagnosis allows clinical interventions when neurological damage is relatively mild, the development of early detection tools has become a major topic of interest. In this article, we review the main neuro-biological and neuropsychological features of Alzheimer's disease, analyzing the use of biomarkers and neuropsychological testing for early detection.
Laboratorio de Neurociencias Cognitivas y Sociocognición, Facultad de Psicología, Universidad Diego Portales, Chile. Renzo.Lanfranco@gmail.com
Renzo G
RG
Lanfranco
Paula
P
Manríquez-Navarro
Leyla G
LG
Avello
Andrés
A
Canales-Johnson
D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis*; D015415:Biomarkers / Q000134:cerebrospinal fluid; D042241:Early Diagnosis; D006801:Humans; D009483:Neuropsychological Tests; D012680:Sensitivity and Specificity
D015415:Biomarkers